Sabitlenmiş Tweet
So cool to see our accelerator @Mayflower_Bio & @MayoClinic featured in the WSJ! wsj.com/articles/mayo-… via @WSJ
English
Anthony Schwartz, PhD
1.8K posts
Anthony Schwartz, PhD
@aschwartzphd
CEO @morphiexbio, EIR @Hibiscusbio, ImmuneOncology Inventor (TLR/#CD47), FDA Aprvl, @JohnsHopkins, former @NCIResearchCtr, Bio Consultant
Saint Petersburg, FL Katılım Mayıs 2014
243 Takip Edilen811 Takipçiler
Anthony Schwartz, PhD retweetledi
first stop codon tRNA drug just entered human trials
@vitarnabio has been working on this for 2 years. mutation-specific suppression targeting arginine nonsense mutations in p53 + DNA repair genes.
@VitaDAO funded it early
Yair Einhorn@yaireinhorn
1/🚨WOW! The first ever tRNA clinical trial has been initiated by @alltrna!🚨 Alltrna announced that it had received an approval to initiate a Phase 1 clinical trial of AP003 in healthy volunteers in Australia. Alltrna’s AP003 is the first tRNA therapeutic to advance into clinical trials, marking a foundational milestone for the field and for patients with Stop Codon Disease! $XBI
English
Anthony Schwartz, PhD retweetledi
The $70 billion/year industry in the US with zero evidence of benefit in healthy people and thousands of paid influencers, by @saraashleyo
gift link wsj.com/health/wellnes…
English
Anthony Schwartz, PhD retweetledi
Person: I would never take the experimental jab!
Same person: So anyway, I injected 46 different peptides yesterday, none of which have any human RCT data nor come from an fda approved manufacturer.
English
Anthony Schwartz, PhD retweetledi
Anthony Schwartz, PhD retweetledi
Merry Christmas $VitaRNA family! We’ve got some cool stuff cooking! Artan-102 is a completely different approach to addressing aging than what’s out there. All of my posts above speak to the science! 2026 is going to 🔥!
x.com/molecule_sci/s…
Michael Torres@Mykalt45
Attention $vitarna holders: New paper mapping how nonsense/frameshift mutations actually cause damage just dropped — and it reinforces a key point for aging biology: cells accumulate truncated, mis-wired proteins as we age. This is exactly the class of variants Artan-102 is built to repair. biorxiv.org/content/10.110… @vitarnabio @vitadao @Molecule_sci @BioProtocol
English
Anthony Schwartz, PhD retweetledi
Attention $VitaRNA token holders: New Nature paper further supports our work: “Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma”
doi.org/10.1038/s41586…
Using deep WGS across >1,000 tumors, this study identifies an endogenous genome-destabilizing program driven by LINE-1 (L1) reactivation that accelerates disease evolution. @vitadao @vitarnabio @Molecule_sci @BioProtocol
English
Anthony Schwartz, PhD retweetledi
I’d like to highlight a new concept called VitaForge that I’m supporting! We’re looking forward to sharing more this week in Abu Dhabi! Longevity and crypto investors take note! @vitadao
Bio Protocol@BioProtocol
DeSci Abu Dhabi Summit Agenda is Live 🎙 Join us next Wednesday, Dec 10, for a day of talks with AI + biotech leaders. Featuring: ➔ Edward Boyden - Neuroscience pioneer & MIT Professor ➔ Simon Li - President of Xtalpi ➔ Axel Bouchon - Co-founder & CEO of Matter Neuroscience ➔ James Magnussen - Olympic swimmer & Enhanced Athlete ➔ Sebastian Brunemeier - Co-founder & Partner at LongGame Ventures ➔ Jonathan Anomaly - Genetics testing entrepreneur & bioethicist + more! RSVP in the link below ⬇️
English
Anthony Schwartz, PhD retweetledi
Hi All. Don't sleep on $VITARNA. Dropping fresh off the press data! In this experiment, we compared two different clinical compatible vectors and tested whether they can rescue nonsense mutations. The data indicates a strong yes! This means we have a solid foundation to scale up for animal studies! More work to do, but we keep pushing forward for the community!
molecule.xyz/dataroom/0xcaD…
Molecule@Molecule_sci
Latest updates: > Manufacturer factory visit > Early scoping underway for potential human trials Every milestone, dataset, and research update streams through Molecule Labs and flows directly into VITARNA's token page.
English
Anthony Schwartz, PhD retweetledi
Tomorrow is the day. Come see how @CrossBridgeBio is leading the way in the next-gen ADC space. We take a holistic approach to ADC design and it starts with our proprietary linker platform. My team and I will be at the poster session the whole time. #Targets25
English
Anthony Schwartz, PhD retweetledi
You guys remember this?! We got back some initial data. We’re still QC’ing, but in the spirit of DeSci and open science to benefit $vitarna token holders, I thought I’d share a few tidbits.
VitaDAO 💛@vitadao
.@vitarnabio/ @artanbio partners with @Syenex to accelerate ARTAN-102 delivery using the VivoCell Platform! This collab combines: > VitaRNA's codon suppressor tech targeting age-related mutations > Syenex's precision in vivo delivery expertise The goal? Speed up the path from proof-of-concept to IND-enabling studies while staying capital-efficient 💊 Led by CSO Dr. Michael Torres ( @Mykalt45), the team's recent safety data shows ARTAN-102 reaches multiple tissues (liver, heart, lung, brain) with no adverse events in mice. 🐭 Next up: Non-human primate studies as they push toward human trials!
English
Anthony Schwartz, PhD retweetledi
What if a single therapy could validate the entire aging thesis?
Michael Torres explains how $VITARNA is built to hit a huge disease target, and open new doors in longevity.
Watch the full episode here:
youtu.be/GBrmoFELIJc
YouTube
English
Anthony Schwartz, PhD retweetledi
Copenhagen Meetup 🇩🇰 Tue Aug 26 / 18:40 hrs
Network State, Radical Life Extension, and Crypto Cities
During the 12th Aging Research and Drug Discovery Meeting (@ARDD_Meeting)
Hosted by @DToddWhite (@TTIScience), and @NiklasAnzinger
Reserve your spot:
lu.ma/infinita-copen…
English
Anthony Schwartz, PhD retweetledi
Today's Longevity Myth: Peptides are safe and natural.
This one is particularly timely, with the report that two people became critically ill from bad peptides given out at a recent conference.
propublica.org/article/peptid…
A lot of peptides promoted in the wellness and longevity space aren’t naturally found in your body—and most haven’t been properly tested for safety or efficacy.
Too many influencers are spreading misinformation about peptides, and I’m disheartened by "longevity doctors" who don’t understand these molecules.
They’re not harmless “biohacks” or nutraceuticals. Peptides are powerful molecules that can act like drugs, with real potential for both benefit and harm.
English
Anthony Schwartz, PhD retweetledi
This is the kind of stuff the longevity community needs to address. There’s a way to do things right, and there are those of us who are on that path…be vigilant and stay away from hype!
Anjeanette Damon@AnjeanetteDamon
NV public health officials are investigating how two women became critically ill after receiving injections at a Las Vegas longevity conference promising pathways to an "unlimited lifespan." The doctor who ran the booth isn't licensed in Nevada My story: propublica.org/article/peptid…
English
Anthony Schwartz, PhD retweetledi
As the Thalion Initiative's research programs get underway we're pleased to have earned our Gold Seal of Transparency with @CandidDotOrg! Get updates on our impact through our #NonprofitProfile app.candid.org/profile/163089…
English
Anthony Schwartz, PhD retweetledi
Keep an eye out on Artan-102 and $vitarna! Latest non-con can be found here: molecule.xyz/ipts/VITARNA
BowTiedBiotech 🧪🔬🧬@BowTiedBiotech
1/ 🚀 Longevity biotech focuses on extending healthy years, not just lifespan Aging populations will cost $7.1T in the US by 2050. One breakthrough - an FDA healthspan label - could reshape medicine and markets. Here’s what’s coming.
English
Anthony Schwartz, PhD retweetledi
What doesn’t work in longevity medicine today?
Direct to consumer biological age and microbiome tests.
Why do I say that?
(1) The don’t measure what they claim to measure
(2) They provide no information on precision or accuracy
(3) There is no industry quality control
(4) There is no regulatory validation
(5) They are not actionable
English
Anthony Schwartz, PhD retweetledi
During my talk I specifically called out these gene therapy clinics and they way they are operating. I suggested one improvement would be an independent body that collects and aggregates the data on both efficacy and adverse events. Afterward folks from the conference shared some pretty chilling stories of people who appear to have been harmed by "longevity" gene therapies, including a previously healthy 30 year old in the prime of his life who is now paralyzed.
IMO, people who are fully informed about the risks involved and the lack of evidence for efficacy - as well as the lack of qualifications of the folks offering these services - should have the right to do whatever they want to their own bodies. Problem is, the risks appear to be being hidden and the likelihood of benefit greatly overstated.
Matt Kaeberlein@mkaeberlein
Sitting here at day 2 of @LongevityDublin feeling uneasy with the presentation from TripleHelix about what they are doing with gene therapy outside of any regulation. Then the guy starts talking about SIRT1 gene therapy, and now I'm certain they don't know what they are doing. Then he starts talking about putting 9 different genes in combination into people based on complete guesses. This isn't science. It's not safe. It's irresponsible experimentation in humans. Glad at least one scientist here had the guts to stand up during Q&A and call it out for what it is. Thank you @ScheibyeKnudsen.
English
Anthony Schwartz, PhD retweetledi
Anthony Schwartz, PhD retweetledi
This is rampant in DeSci and the Longevity space. I hope folks stay disciplined and discerning. How about we promote and support science-grounded approaches that have transformative potential…like @artan_bio / @vitarnabio. We’ll continue to do our part!
Matt Kaeberlein@mkaeberlein
Sitting here at day 2 of @LongevityDublin feeling uneasy with the presentation from TripleHelix about what they are doing with gene therapy outside of any regulation. Then the guy starts talking about SIRT1 gene therapy, and now I'm certain they don't know what they are doing. Then he starts talking about putting 9 different genes in combination into people based on complete guesses. This isn't science. It's not safe. It's irresponsible experimentation in humans. Glad at least one scientist here had the guts to stand up during Q&A and call it out for what it is. Thank you @ScheibyeKnudsen.
English